No Oral HPV infection | Oral HPV Infection | |||||
---|---|---|---|---|---|---|
Characteristic | N | (%) | N | (%) | P-valued | OR (95% CI)d |
Total N | 225 | (76) | 70 | (24) | ||
Study Site | 0.2604 | |||||
CMC, Vellore | 117 | (79) | 31 | (21) | 1.0 | |
HT, Mumbai | 108 | (73) | 39 | (27) | 1.4 (0.8–2.3) | |
Age Categoriesa | 0.5064 | |||||
18–25 | 33 | (79) | 9 | (21) | 1.0 | |
26–35 | 92 | (79) | 24 | (21) | 1.0 (0.4–2.3) | |
35+ | 93 | (73) | 34 | (27) | 1.3 (0.6–3.1) | |
Highest number of years of school completed | 0.7635 | |||||
None | 40 | (80) | 10 | (20) | 1.0 | |
1–10 | 145 | (76) | 46 | (24) | 1.3 (0.6–2.7) | |
10+ | 40 | (74) | 14 | (26) | 1.4 (0.6–3.5) | |
Monthly income (mean ± SD) | 4268 | (±4128) | 5621 | (±6320) | 0.0970 | 1.0 (1.0–1.0) |
Religion | 0.4865 | |||||
Hindu | 175 | (75) | 58 | (25) | 1.0 | |
Muslim | 31 | (77) | 9 | (23) | 0.9 (0.4–1.9) | |
Other | 19 | (86) | 3 | (14) | 0.5 (0.1–1.7) | |
Marital Status | . | 0.9519 | ||||
Unmarried | 118 | (76) | 37 | (24) | 1.0 | |
Married | 107 | (76) | 33 | (24) | 1.0 (0.6–1.7) | |
Smoked more than 100 lifetime cigarettes | . | 0.5269 | ||||
No | 160 | (77) | 47 | (23) | 1.0 | |
Yes | 65 | (74) | 23 | (26) | 1.2 (0.7–2.1) | |
Mean years smoked | 4 | (±8) | 4 | (±7) | 0.8550 | 1.0 (1.0–1.0) |
Chews tobacco ‘regularly’b | . | 0.0077 | ||||
No | 145 | (72) | 57 | (28) | 1.0 | |
Yes | 80 | (86) | 13 | (14) | 0.4 (0.2–0.8) | |
If Yes: How often chew tobacco on average per week | 0.0709 | |||||
< 2 days/week | 22 | (100) | 0 | (0) | NE | |
3–5 days/week | 9 | (90) | 1 | (10) | 1.0 | |
6–7 days/week | 49 | (80) | 12 | (20) | 7.6 (0.9–61.3)e | |
Consumes alcohol | 0.2531 | |||||
No | 95 | (73) | 35 | (27) | 1.0 | |
Yes | 130 | (79) | 35 | (21) | 0.7 (0.4–1.3) | |
CD4 (cells/uL)c | . | 0.0106 | ||||
< 200 | 21 | (57) | 16 | (43) | 3.1 (1.4–6.9) | |
200–500 | 113 | (78) | 31 | (22) | 1.1 (0.6–2.0) | |
500+ | 89 | (80) | 22 | (20) | 1.0 | |
HIV viral loadc | . | 0.4570 | ||||
Undetectable | 77 | (73) | 28 | (27) | 1.0 | |
> 400–37,400 | 72 | (81) | 17 | (19) | 0.6 (0.3–1.3) | |
> 37,400 | 75 | (76) | 24 | (24) | 0.9 (0.5–1.7) | |
Antiretroviral therapy use | 0.2227 | |||||
No | 128 | (79) | 34 | (21) | 1.0 | |
Yes | 97 | (73) | 36 | (27) | 1.4 (0.8–2.4) |